Engineering biology and chemical approaches to the construction of vitamin B12 analogues and antivitamins B12 as probes and therapeutic agents
Advances in Microbial Physiology · 2025
DOI: 10.1016/bs.ampbs.2025.07.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Microbial Physiology, 2025. Verfasst von Michael D Paxhia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quadram Institute Bioscience, Norwich, UK. Hauptthemen laut MEDLINE: Vitamin B 12, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: Austrian Science Fund, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Vitamins are indispensable cofactors that expand the chemical capabilities of enzymes beyond the inherent limitations of amino acid side chains. Among them, vitamin B₁₂ is particularly remarkable due to its exceptional structural complexity, the presence of a cobalt-centered corrin ring, and its exclusive biosynthetic origin in prokaryotes. This review explores the biosynthesis, transport, and biological significance of B₁₂, with an emphasis on the growing toolbox of synthetic analogues designed for research and therapeutic use. Recent advances in synthetic biology have enabled the complete heterologous expression of the aerobic B12 biosynthesis pathway in Escherichia coli, facilitating the high-yield production of biosynthetic intermediates and cobalt-free B12-precursors. These intermediates serve as platforms for the generation of metbalamins, metal-substituted cobalamin analogues incorporating rhodium, nickel, zinc, and other transition metals. In parallel, novel organo-antimetabolites and fluorescently labelled derivatives have been developed to probe B₁₂-dependent enzymes, trace vitamin transport in living systems, and selectively disrupt microbial or disease-linked metabolism. These synthetic analogues function as versatile tools for imaging, mechanistic dissection, and metabolic inhibition and more specifically in the case of molecules that counteract the physiological effects of vitamin B12 in animal systems hold potential as antivitamins B12. Collectively, they offer powerful new approaches to study nutrient trafficking, engineer cofactor interactions, and develop targeted antimicrobial or anticancer strategies. The review concludes by discussing future directions in applying engineering biology and chemical synthesis to further diversify and exploit the functional potential of the cobalamin scaffold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quadram Institute Bioscience, Norwich, UK.
- School of Biosciences, University of Kent, Canterbury, UK.
- Institute for Organic Chemistry, University of Innsbruck, Innsbruck, Austria. Electronic address: Bernhard.Kraeutler@uibk.ac.at.
- Quadram Institute Bioscience, Norwich, UK; School of Biosciences, University of Kent, Canterbury, UK; University of East Anglia, Norwich, UK. Electronic address: Martin.Warren@quadram.ac.uk.
Förderung
- Austrian Science Fund
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Paxhia, M. D., Hartshorn, F. L., Deery, E., Kräutler, B., & Warren, M. J. (2025). Engineering biology and chemical approaches to the construction of vitamin B12 analogues and antivitamins B12 as probes and therapeutic agents. Advances in Microbial Physiology. https://doi.org/10.1016/bs.ampbs.2025.07.003
Vancouver
Paxhia MD, Hartshorn FL, Deery E, Kräutler B, Warren MJ. Engineering biology and chemical approaches to the construction of vitamin B12 analogues and antivitamins B12 as probes and therapeutic agents. Advances in Microbial Physiology. 2025. doi:10.1016/bs.ampbs.2025.07.003
BibTeX
@article{Paxhia2025,
author = {Paxhia, Michael D and Hartshorn, Freya L and Deery, Evelyne and Kräutler, Bernhard and Warren, Martin J},
title = {Engineering biology and chemical approaches to the construction of vitamin B12 analogues and antivitamins B12 as probes and therapeutic agents},
journal = {Advances in Microbial Physiology},
year = {2025},
doi = {10.1016/bs.ampbs.2025.07.003}
}
EUVIMED